Twist Bioscience Corp. (TWST)
103.32
-8.30
(-7.44%)
USD |
NASDAQ |
Nov 20, 16:00
105.20
+1.88
(+1.82%)
After-Hours: 20:00
Twist Bioscience Research and Development Expense (TTM) : 71.84M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 71.84M |
| June 30, 2026 | 71.86M |
| March 31, 2026 | 71.89M |
| December 31, 2025 | 76.11M |
| September 30, 2025 | 80.28M |
| June 30, 2025 | 84.40M |
| March 31, 2025 | 88.83M |
| December 31, 2024 | 89.06M |
| September 30, 2024 | 90.85M |
| June 30, 2024 | 93.46M |
| March 31, 2024 | 95.52M |
| December 31, 2023 | 98.75M |
| September 30, 2023 | 106.89M |
| June 30, 2023 | 112.76M |
| March 31, 2023 | 125.07M |
| December 31, 2022 | 128.92M |
| September 30, 2022 | 120.31M |
| June 30, 2022 | 110.14M |
| March 31, 2022 | 93.14M |
| Date | Value |
|---|---|
| December 31, 2021 | 77.70M |
| September 30, 2021 | 69.07M |
| June 30, 2021 | 61.26M |
| March 31, 2021 | 51.87M |
| December 31, 2020 | 46.71M |
| September 30, 2020 | 43.01M |
| June 30, 2020 | 41.87M |
| March 31, 2020 | 40.43M |
| December 31, 2019 | 38.71M |
| September 30, 2019 | 35.68M |
| June 30, 2019 | 31.25M |
| March 31, 2019 | 27.51M |
| December 31, 2018 | 23.32M |
| September 30, 2018 | 20.35M |
| June 30, 2018 | 19.13M |
| March 31, 2018 | 19.14M |
| December 31, 2017 | 19.14M |
| September 30, 2017 | 19.17M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 326.72M |
| Beam Therapeutics, Inc. | 409.00M |
| 10X Genomics, Inc. | 222.54M |
| Prime Medicine, Inc. | 136.33M |
| Moderna, Inc. | 2.401B |